Literature DB >> 17616817

Association between proton pump inhibitor use and spontaneous bacterial peritonitis.

Mical S Campbell1, Keith Obstein, K Rajender Reddy, Yu-Xiao Yang.   

Abstract

Proton pump inhibitors (PPIs) increase enteric bacterial colonization, overgrowth, and translocation, all effects which might predispose to spontaneous bacterial peritonitis. We investigated whether PPI usage is associated with spontaneous bacterial peritonitis. Our retrospective case-control study included 116 consecutive cirrhotic patients with ascites who underwent diagnostic paracentesis upon hospital admission (2002-2005). Spontaneous bacterial peritonitis was defined as paracentesis yielding >or=250 polymorphonuclear leukocytes/ml. We performed logistic regression to determine the risk of spontaneous bacterial peritonitis by PPI usage. Of the 116 subjects, 32 had spontaneous bacterial peritonitis. Patient characteristics were similar between groups with and without infection, with the exception of the Model for End-Stage Liver Disease score (median: 23 and 18, respectively; P = 0.002). Crude and adjusted odds ratios for the development of spontaneous bacterial peritonitis by exposure to PPIs were 1.22 (95% confidence interval: 0.52-2.87) and 1.05 (0.43-2.57), respectively. In conclusion, we did not find a positive association between PPI use and spontaneous bacterial peritonitis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17616817     DOI: 10.1007/s10620-007-9899-9

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  24 in total

1.  Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease.

Authors:  Sandra Dial; J A C Delaney; Alan N Barkun; Samy Suissa
Journal:  JAMA       Date:  2005-12-21       Impact factor: 56.272

2.  A new mechanism for anti-inflammatory actions of proton pump inhibitors--inhibitory effects on neutrophil-endothelial cell interactions.

Authors:  N Yoshida; T Yoshikawa; Y Tanaka; N Fujita; K Kassai; Y Naito; M Kondo
Journal:  Aliment Pharmacol Ther       Date:  2000-04       Impact factor: 8.171

3.  The impact of confounder selection criteria on effect estimation.

Authors:  R M Mickey; S Greenland
Journal:  Am J Epidemiol       Date:  1989-01       Impact factor: 4.897

4.  Intestinal bacterial overgrowth and bacterial translocation in cirrhotic rats with ascites.

Authors:  C Guarner; B A Runyon; S Young; M Heck; M Y Sheikh
Journal:  J Hepatol       Date:  1997-06       Impact factor: 25.083

5.  Spontaneous bacterial peritonitis: a prospective investigation in predominantly nonalcoholic cirrhotic patients.

Authors:  G Pinzello; R G Simonetti; A Craxì; S Di Piazza; C Spanò; L Pagliaro
Journal:  Hepatology       Date:  1983 Jul-Aug       Impact factor: 17.425

6.  Small intestinal bacterial overgrowth in patients with cirrhosis: prevalence and relation with spontaneous bacterial peritonitis.

Authors:  T M Bauer; B Steinbrückner; F E Brinkmann; A K Ditzen; H Schwacha; J J Aponte; K Pelz; M Kist; H E Blum
Journal:  Am J Gastroenterol       Date:  2001-10       Impact factor: 10.864

7.  Bacterial translocation of enteric organisms in patients with cirrhosis.

Authors:  I Cirera; T M Bauer; M Navasa; J Vila; L Grande; P Taurá; J Fuster; J C García-Valdecasas; A Lacy; M J Suárez; A Rimola; J Rodés
Journal:  J Hepatol       Date:  2001-01       Impact factor: 25.083

8.  Gastric acid suppression does not promote clostridial diarrhoea in the elderly.

Authors:  S Shah; A Lewis; D Leopold; F Dunstan; K Woodhouse
Journal:  QJM       Date:  2000-03

9.  Patients with deficient ascitic fluid opsonic activity are predisposed to spontaneous bacterial peritonitis.

Authors:  B A Runyon
Journal:  Hepatology       Date:  1988 May-Jun       Impact factor: 17.425

10.  The effect of gastric secretion on orocoecal transit time measured with the hydrogen (H2) breath test.

Authors:  U Armbrecht; G Dotevall; R W Stockbrügger
Journal:  Z Gastroenterol       Date:  1987-03       Impact factor: 2.000

View more
  19 in total

1.  Immunology and the evaluation of risk factors for development of spontaneous bacterial peritonitis.

Authors:  Charles J Diskin
Journal:  Dig Dis Sci       Date:  2007-10-17       Impact factor: 3.199

2.  The burden of extended-spectrum β-lactamase-producing Enterobacteriaceae in patients with cirrhosis.

Authors:  Richard Moreau
Journal:  Hepatol Int       Date:  2014-09-06       Impact factor: 6.047

3.  Correlation between proton pump inhibitors and risk of pyogenic liver abscess.

Authors:  Hsien-Feng Lin; Kuan-Fu Liao; Ching-Mei Chang; Cheng-Li Lin; Shih-Wei Lai
Journal:  Eur J Clin Pharmacol       Date:  2017-04-22       Impact factor: 2.953

Review 4.  Bacterial infections in cirrhosis: A critical review and practical guidance.

Authors:  Chalermrat Bunchorntavakul; Naichaya Chamroonkul; Disaya Chavalitdhamrong
Journal:  World J Hepatol       Date:  2016-02-28

Review 5.  Association Between Proton Pump Inhibitor Therapy and Spontaneous Bacterial Peritonitis Occurrence in Cirrhotic Patients: A Clinical Review.

Authors:  Meng Zhang; Wei Liu; Xin Xu; Tao Chen; Jun-Ying Qi
Journal:  Curr Med Sci       Date:  2022-07-23

6.  Diagnosis and management of bacterial infections in decompensated cirrhosis.

Authors:  Maria Pleguezuelo; Jose Manuel Benitez; Juan Jurado; Jose Luis Montero; Manuel De la Mata
Journal:  World J Hepatol       Date:  2013-01-27

7.  Proton Pump Inhibitor Therapy Increases the Risk of Spontaneous Bacterial Peritonitis in Patients with HBV-Related Acute-on-Chronic Liver Failure.

Authors:  Meng Zhang; Xin Xu; Wei Liu; Zhongwei Zhang; Qiuyu Cheng; Zhongyuan Yang; Tingting Liu; Yunhui Liu; Qin Ning; Tao Chen; Junying Qi
Journal:  Adv Ther       Date:  2021-07-25       Impact factor: 3.845

8.  Association between proton pump inhibitor use and spontaneous bacterial peritonitis in cirrhotic patients with ascites.

Authors:  Melissa Ratelle; Sylvie Perreault; Jean-Pierre Villeneuve; Lydjie Tremblay
Journal:  Can J Gastroenterol Hepatol       Date:  2014-06

9.  The impact of proton-pump inhibitors on intraperitoneal sepsis: a word of caution for transgastric NOTES procedures.

Authors:  Sonia L Ramamoorthy; Jeffrey K Lee; Yoav Mintz; John Cullen; Michelle K Savu; David W Easter; Alana Chock; Ravi Mittal; Santiago Horgan; Mark A Talamini
Journal:  Surg Endosc       Date:  2009-06-24       Impact factor: 4.584

10.  Increased Risk of Spontaneous Bacterial Peritonitis in Cirrhotic Patients Using Proton Pump Inhibitors.

Authors:  Abdel-Naser Elzouki; Nadia Neffati; Fatma A Rasoul; Ali Abdallah; Muftah Othman; Abdelkarim Waness
Journal:  GE Port J Gastroenterol       Date:  2018-06-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.